Targeting COVID-19 and cancer with immunotherapy advancementsAnna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform. Over the last 30 years, we Share XTargeting COVID-19 and cancer with immunotherapy advancementshttps://pharmaphorum.com/r-d/targeting-covid-19-cancer-immunotherapy-advancements/
